From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Decision Making – Hepatitis C In Children

First published:

2021

Last published:

2024

Overview

Last clinical update: March 2024
Latest version: December 2024, updated with HepLink Australia details. 

This two-page summary was developed from the HCV in Children: Australian Commentary on AASLD-IDSA Guidance. The resource supports clinicians to provide advice and manage hepatitis C in children.

Page 1 provides recommendations on which tests to order and when testing of babies born to mothers with hepatitis C infection should occur.

Page 2 covers natural history; transmission and prevention; parental advice; HCV treatment; monitoring and medical management, including lifestyle recommendations; and specialist referral indications.